Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study

<div>Kaplan-Meier analysis of percentage of patients remaining hospitalized over time in the warfarin plus enoxaparin versus rivaroxaban groups.</div>

Thrombosis

fig2

Figure 2

Figure 2: Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study 

Figure 2 | Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study 